CIRCULATING FIBRINOLYSIN IN A CASE OF PROSTATIC CARCINOMA WITH BONY METASTASES
Authors: S BERGEN, F J SCHILLING
Journal: Annals of Internal Medicine (1958)

Case Reports1 February 1958CIRCULATING FIBRINOLYSIN IN A CASE OF PROSTATIC CARCINOMA WITH BONY METASTASESSTANLEY BERGEN JR., M.D., FRED J. SCHILLING, M.D., F.A.C.P.STANLEY BERGEN JR., M.D.Search for more papers by this author, FRED J. SCHILLING, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-48-2-389 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptDuring the last few years sporadic cases of afibrinogenemia and hypofibrinogenemia have been appearing in the literature. Diminished levels or total lack of fibrinogen has occasionally been noted as a congenital abnormality,6, 17but usually this disturbance in hemostasis is acquired. The earliest recorded cases were reported in shock, or in hemorrhagic,1, 24traumatic24or anaphylactic response to antigens.24A decrease of plasma fibrinogen levels has been noted in cases of severe liver necrosis from phenobarbital and methyl alcohol34and chloroform.24More recently, afibrinogenemia has been reported following pulmonary operations,15in preëclampsia, the first day of menstruation,35amniotic fluid embolus,18...Bibliography1. CoonHodgson WWPE: Fibrinolysis in surgery patients. I. Possible relaship to hemorrhagic diathesis, Surg., Gynec. and Obst. 95: 717, 1952. MedlineGoogle Scholar2. CoopermanNeiman AAGM: Fibrinogenopenia and fibrinolysis in acute myelogenous leukemia, Ann. Int. Med. 42: 706, 1955. LinkGoogle Scholar3. DingleThomas JTDP: Cup-plate assay of serum fibrinolysin, Nature, London 175: 728, 1955. CrossrefMedlineGoogle Scholar4. DolazDolehideFriedman EJRAIA: Fibrinolysis in patients with metastatic carcinoma of the prostate gland, Illinois M. J. 107: 142, 1955. MedlineGoogle Scholar5. FrickMcKelvey PGJL: Hemorrhagic diathesis with hypofibrinogenemia following fetal death in utero, Am. J. Obst. and Gynec. 70: 328, 1955. CrossrefMedlineGoogle Scholar6. HendersonDonaldsonScarborough JLGMM: Congenital afibrinogenemia; report of a case with a review of the literature, Quart. J. Med. 14: 101, 1945. Google Scholar7. HugginsNeal CW: Coagulation and liquefaction of semen, proteolytic enzymes, and citrate in prostatic fluid, J. Exper. Med. 76: 527, 1942. CrossrefMedlineGoogle Scholar8. HugginsVail CVC: Plasma coagulation and fibrinogenolysis by prostatic fluid and trypsin, Am. J. Physiol. 139: 129, 1943. CrossrefGoogle Scholar9. JürgensTrautwein RH: Über Fibrinopenie beim Erwachsenen, nebst Bemerkungen über die Herkunft des Fibrinogens, Deutsches Arch. f. klin. Med. 169: 28, 1930. Google Scholar10. LewisFerguson JHJH: Studies on a proteolytic enzyme system of the blood. IV. Activation of profibrinolysin by serum fibrinolysokinase, Proc. Soc. Exper. Biol. and Med. 78: 184, 1951. CrossrefMedlineGoogle Scholar11. MacFarlaneBiggs RGR: Fibrinolysis. Its mechanism and significance, Blood 3: 1167, 1948. CrossrefMedlineGoogle Scholar12. MarderWeinerSchulmanShapiro MMPS: Afibrinogenemia occurring in a case of malignancy of the prostate with bone metastases, New York State J. Med. 49: 1197, 1949. MedlineGoogle Scholar13. MoloneyEganGorman WCWJAJ: Acquired afibrinogenemia in pregnancy, New England J. Med. 240: 596, 1949. CrossrefMedlineGoogle Scholar14. MurphySchwippert WTH: Pituitary irradiation in prostatic carcinoma, Radiology 56: 376, 1951. CrossrefMedlineGoogle Scholar15. PennWalker SRJH: Defective blood coagulation following pulmonary surgery, New England J. Med. 250: 764, 1954. CrossrefMedlineGoogle Scholar16. Peterman EA: Plasma fibrinogen level. I. Mechanism, observation, and interpretation J. Michigan M. Soc. 54: 308, 1955. MedlineGoogle Scholar17. Prentice AI: A case of congenital afibrinogenemia, Lancet 1: 211 (Jan. 27) 1951. CrossrefMedlineGoogle Scholar18. ReidWeinerRoby DEAECC: I. Intravascular clotting and afibrinogenemia, the presumptive lethal factor in the syndrome of amniotic fluid embolism, Am. J. Obst. and Gynec. 66: 465, 1953. CrossrefMedlineGoogle Scholar19. ReidWeinerRobyDiamond DEAECCLK: III. Maternal afibrinogenemia associated with long standing intrauterine fetal death, Am. J. Obst. and Gynec. 66: 500, 1953. CrossrefMedlineGoogle Scholar20. SealeJampolisBargen RARWJA: Clotting defect in the presence of metastatic carcinoma of the prostate, S. Clin. North America 31: 1111, 1951. CrossrefMedlineGoogle Scholar21. ShulmanTagnon NRHJ: Proteolytic activity determined with a substrate tagged with radioactive iodine, J. Biol. Chem. 186: 69, 1950. CrossrefMedlineGoogle Scholar22. StefaniniCampbellPlitmanSalomon MEWGIL: Coagulation defects due to acquired anticoagulants and fibrinolysins; their detection and treatment, Bull. New England M. Center 15: 23, 1953. MedlineGoogle Scholar23. Stefanini M: Fibrinolysis and "fibrinolytic purpura," Blood 7: 1044, 1952. CrossrefMedlineGoogle Scholar24. TagnonLevensonDavidsonTaylor HJSMCSFH: The occurrence of fibrinolysis in shock with observations on prothrombin time and plasma fibrinogen during hemorrhagic shock, Am. J. M. Sc. 211: 88, 1946. CrossrefMedlineGoogle Scholar25. Tagnon HJ: The significance of fibrinolysis in mechanism of coagulation of blood, J. Lab. and Clin. Med. 27: 1119, 1942. Google Scholar26. TagnonWhitmoreShulman HJWFNR: Fibrinolysis in metastatic cancer of the prostate, Cancer 5: 9, 1952. CrossrefMedlineGoogle Scholar27. TagnonSchulmanWhitmoreKravitz HJPWFSC: The hemorrhagic syndrome of metastatic prostatic cancer and its treatment, J. Clin. Investigation 31: 666, 1952. Google Scholar28. TagnonWhitmoreSchulmanKravitz HJWFPSC: The significance of fibrinolysis occurring in patients with metastatic cancer of the prostate, Cancer 6: 63, 1953. CrossrefMedlineGoogle Scholar29. TagnonSchulmanWhitmoreLeone HJPWFLA: Prostatic fibrinolysin—study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate, Am. J. Med. 15: 875, 1955. CrossrefGoogle Scholar30. TillettGarner WSRL: The fibrinolytic activity of hemolytic streptococci, J. Exper. Med. 58: 485, 1933. CrossrefMedlineGoogle Scholar31. VigilanteBehringer MFR: Afibrinogenemia—report of a case associated with long-standing fetal death in utero and Rh isosensitization, Obst. and Gynec. 6: 434, 1955. Google Scholar32. WeinerReidRoby AEDECC: Coagulation defects associated with premature separation of the normally implanted placenta, Am. J. Obst. and Gynec. 60: 379, 1950. CrossrefMedlineGoogle Scholar33. WeinerReidRoby AEDECC: II. Incoagulable blood in severe premature separation of the placenta: a method of management, Am. J. Obst. and Gynec. 66: 475, 1953. CrossrefMedlineGoogle Scholar34. WhippleHurwitz GHSH: Fibrinogen of the blood as influenced by the liver necrosis of chloroform poisoning, J. Exper. Med. 13: 136, 1911. CrossrefMedlineGoogle Scholar35. WillsonMunnell JRER: Fibrinolytic activity in blood serum during pregnancy complicated by hypertensive toxemias, Proc. Soc. Exper. Biol. and Med. 62: 277, 1946. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: New York, N. Y.*Received for publication August 2, 1956.From the Department of Medicine, St. Luke's Hospital, New York, N. Y.Requests for reprints should be addressed to Stanley Bergen, Jr., M.D., 421 West 113th Street, New York 25, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byDISSEMINATED INTRAVASCULAR COAGULOPATHY (DIC) COMPLICATING INTRAMEDULLARY FIXATION OF IMPENDING FEMUR FRACTURE FROM METASTATIC PROSTATE CANCERCoagulation intravasculaire disséminée associée au cancer de la prostateManifestations of Advanced Prostate Cancer: Prognosis and TreatmentParaneoplastic Syndromes Associated with Prostatic CarcinomaAcute gastrointestinal bleeding as the presenting manifestation of prostate CancerBLEEDING AND INTRAVASCULAR CLOTTING IN MALIGNANCY: A REVIEWThrombohämorrhagische Phänomene bei KrebserkrankungenHeparin-Induced Thrombocytopenia An Unexpected Response to Treatment of Consumption CoagulopathyETHAN A. NATELSON, M.D., EDWARD C. LYNCH, M.D., F.A.C.P., CLARENCE P. ALFREY JR., M.D., F.A.C.P., JAMES B. GROSS, M.D.Hypofibrinogenaemia in metastatic carcinoma of the prostate: suppression of systemic fibrinolysis by heparinBlutplättchen und gerinnungsaktive Plasmaproteine Ein kurzer Abriß ihrer Funktion und PathologieAn Analysis of Medical Problems In CancerCoexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma 1 February 1958Volume 48, Issue 2Page: 389-398KeywordsAdenocarcinomaBlood plasmaEstrogensFibrinogenHospital medicineLiverNecrosisPhosphatasesPreeclampsiaShock ePublished: 1 December 2008 Issue Published: 1 February 1958 PDF downloadLoading ...